Characteristics

All

Alive

(N = 54)

Died

(N = 16)

p-value

(N = 70)

No.

%

No.

%

No.

%

Age (years)

Mean ± SD

50.24 ± 9.58

49.92 ± 9.57

51.31 ± 9.85

0.524Ÿ

Median

(Range)

52.50

(27 - 62)

52

(27 - 62)

54

(28 - 61)

Grade

Low

18

27.7%

16

88.9%

2

11.1%

0.209‡

High

52

74.3%

38

73.1%

14

26.9%

LN

Negative

22

31.4%

21

95.5%

1

4.5%

0.014‡

Positive

48

68.6%

33

68.8%

15

31.2%

Stage

Stage I

8

11.4%

8

100%

0

0%

0.056§

Stage II

12

17.1%

10

83.3%

2

16.7%

Stage III

32

45.7%

24

75%

8

25%

Stage IV

18

25.7%

12

66.7%

6

33.3%

CA125 (u/ml)

Mean ± SD

1071.31 ± 666.91

960.01 ± 670.88

1446.93 ± 510.49

0.009Ÿ

Median

(Range)

1238.50

(69 - 2008)

1233.50

(69 - 2005)

1253.50

(90 - 2008)

Gal-1 (ng/ml)

Mean ± SD

334.84 ± 187.67

296.25 ± 174.70

465.05 ± 175.31

<0.001Ÿ

Median

(Range)

277

(32 - 763)

271

(32 - 649)

380

(280 - 763)

Gal-1

Weak

22

31.4%

22

100%

0

0%

0.002‡

Strong

48

68.6%

32

66.7%

16

33.3%

Gal-1 tumor cells

Weak

24

34.3%

21

87.5%

3

12.5%

0.136‡

Strong

46

65.7%

33

71.7%

13

28.3%